Dexcel Pharma
Asia, Yerushalayim, Israel, Jerusalem
Description
Dexcel Pharma is an international specialty pharmaceutical company.
Investor Profile
Dexcel Pharma has backed more than 7 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 14% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Private Equity, Series B rounds (top funding stages).
- Majority of deals are located in United States, Israel.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
Stage Focus
- Series A (29%)
- Private Equity (29%)
- Series B (14%)
- Series C (14%)
- Series Unknown (14%)
Country Focus
- United States (86%)
- Israel (14%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Biopharma
- Pharmaceutical
- Product Research
- Analytics
- Artificial Intelligence (Ai)
- Machine Learning
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Dexcel Pharma frequently co-invest with?
Which angels does Dexcel Pharma often collaborate with?
What are some of recent deals done by Dexcel Pharma?
Find More Investors Like Dexcel Pharma
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
